- CancerNetwork.com
- CureToday.com
- OncLive.com
- TargetedOnc.com
- Privacy
- Terms & Conditions
- Do Not Sell My Information
© 2022 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Laura Tang on Classifications of Neuroendocrine Tumors
Laura Tang, MD, PhD, a pathologist at Memorial Sloan Kettering Cancer Center, discusses the classifications of advanced neuroendocrine tumors (NETs).
Laura Tang, MD, PhD, a pathologist at Memorial Sloan Kettering Cancer Center, discusses the classifications of advanced neuroendocrine tumors (NETs).
NETs are classified as well-differentiated or poorly-differentiated.
Patients with well-differentiated, high grade (G3) NETs generally do not experience symptoms and their tumors are often diagnosed incidentally.
Patients with poorly-differentiated tumors are typically very ill and present with dramatic symptoms such as abdominal pain, weight loss, and jaundice.